{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T14:07:55Z","timestamp":1756994875828,"version":"3.40.3"},"reference-count":213,"publisher":"Elsevier","isbn-type":[{"type":"print","value":"9780323853019"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004185","name":"Northern Counties Kidney Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000291","name":"Kidney Research UK","doi-asserted-by":"publisher","award":["RP_006_20180227"],"award-info":[{"award-number":["RP_006_20180227"]}],"id":[{"id":"10.13039\/501100000291","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/bs.pmbts.2021.01.027","type":"book-chapter","created":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T15:34:15Z","timestamp":1615131255000},"page":"353-401","source":"Crossref","is-referenced-by-count":7,"title":["Gene and epigenetic editing in the treatment of primary ciliopathies"],"prefix":"10.1016","author":[{"given":"Elisa","family":"Molinari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Sayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/bs.pmbts.2021.01.027_bb0010","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.tcb.2016.08.002","article-title":"The cilium: cellular antenna and central processing unit","volume":"27","author":"Malicki","year":"2017","journal-title":"Trends Cell Biol"},{"issue":"7","key":"10.1016\/bs.pmbts.2021.01.027_bb0015","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41580-019-0116-4","article-title":"Establishing and regulating the composition of cilia for signal transduction","volume":"20","author":"Nachury","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5787","key":"10.1016\/bs.pmbts.2021.01.027_bb0020","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1126\/science.1124534","article-title":"The primary cilium as the cell's antenna: signaling at a sensory organelle","volume":"313","author":"Singla","year":"2006","journal-title":"Science"},{"key":"10.1016\/bs.pmbts.2021.01.027_bb0025","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3389\/fcell.2018.00008","article-title":"Signaling through the primary cilium","volume":"6","author":"Wheway","year":"2018","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/bs.pmbts.2021.01.027_bb0030","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.gde.2019.05.004","article-title":"The photoreceptor cilium and its diseases","volume":"56","author":"Bachmann-Gagescu","year":"2019","journal-title":"Curr Opin Genet Dev"},{"issue":"12","key":"10.1016\/bs.pmbts.2021.01.027_bb0035","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/nrg1727","article-title":"Cilia and centrosomes: a unifying pathogenic concept for cystic kidney disease?","volume":"6","author":"Hildebrandt","year":"2005","journal-title":"Nat Rev Genet"},{"key":"10.1016\/bs.pmbts.2021.01.027_bb0040","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1146\/annurev.genom.7.080505.115610","article-title":"The ciliopathies: an emerging class of human genetic disorders","volume":"7","author":"Badano","year":"2006","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"3","key":"10.1016\/bs.pmbts.2021.01.027_bb0045","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1073\/pnas.93.3.1156","article-title":"Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain","volume":"93","author":"Kim","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/bs.pmbts.2021.01.027_bb0050","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1534\/genetics.110.120717","article-title":"Targeting DNA double-strand breaks with TAL effector nucleases","volume":"186","author":"Christian","year":"2010","journal-title":"Genetics"},{"issue":"1","key":"10.1016\/bs.pmbts.2021.01.027_bb0055","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/nar\/gkq704","article-title":"TAL nucleases (TALNs): hybrid proteins composed of TAL effectors and FokI DNA-cleavage domain","volume":"39","author":"Li","year":"2011","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"10.1016\/bs.pmbts.2021.01.027_bb0060","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1073\/pnas.1019533108","article-title":"De novo-engineered transcription activator-like effector (TALE) hybrid nuclease with novel DNA binding specificity creates double-strand breaks","volume":"108","author":"Mahfouz","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"39","key":"10.1016\/bs.pmbts.2021.01.027_bb0065","doi-asserted-by":"crossref","first-page":"E2579","DOI":"10.1073\/pnas.1208507109","article-title":"Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria","volume":"109","author":"Gasiunas","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6096","key":"10.1016\/bs.pmbts.2021.01.027_bb0070","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"issue":"6121","key":"10.1016\/bs.pmbts.2021.01.027_bb0075","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"issue":"7","key":"10.1016\/bs.pmbts.2021.01.027_bb0080","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41587-020-0561-9","article-title":"Genome editing with CRISPR\u2013Cas nucleases, base editors, transposases and prime editors","volume":"38","author":"Anzalone","year":"2020","journal-title":"Nat Biotechnol"},{"issue":"1","key":"10.1016\/bs.pmbts.2021.01.027_bb0085","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ajhg.2017.05.010","article-title":"Mutations in ARMC9, which encodes a basal body protein, cause Joubert syndrome in humans and ciliopathy phenotypes in Zebrafish","volume":"101","author":"Van De Weghe","year":"2017","journal-title":"Am J Hum Genet"},{"issue":"7","key":"10.1016\/bs.pmbts.2021.01.027_bb0090","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/j.celrep.2019.07.025","article-title":"A CEP104-CSPP1 complex is required for formation of primary cilia competent in hedgehog signaling","volume":"28","author":"Frikstad","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/bs.pmbts.2021.01.027_bb0095","doi-asserted-by":"crossref","DOI":"10.1172\/JCI131656","article-title":"Dysfunction of the ciliary ARMC9\/TOGARAM1 protein module causes Joubert syndrome","author":"Latour","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/bs.pmbts.2021.01.027_bb0100","article-title":"Biallelic mutations in the TOGARAM1 gene cause a novel primary ciliopathy","author":"Morbidoni","year":"2020","journal-title":"J Med Genet"},{"issue":"3","key":"10.1016\/bs.pmbts.2021.01.027_bb0105","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s41588-018-0054-7","article-title":"A CRISPR-based screen for Hedgehog signaling provides insights into ciliary function and ciliopathies","volume":"50","author":"Breslow","year":"2018","journal-title":"Nat Genet"},{"issue":"10","key":"10.1016\/bs.pmbts.2021.01.027_bb0110","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1038\/eye.2008.382","article-title":"Ocular immune privilege","volume":"23","author":"Taylor","year":"2009","journal-title":"Eye"},{"issue":"4","key":"10.1016\/bs.pmbts.2021.01.027_bb0115","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/ki.1995.406","article-title":"Renal uptake of an 18-mer phosphorothioate oligonucleotide","volume":"48","author":"Oberbauer","year":"1995","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/bs.pmbts.2021.01.027_bb0120","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1089\/oli.1.1998.8.451","article-title":"Cellular distribution of phosphorothioate oligonucleotide following intravenous administration in mice","volume":"8","author":"Zhao","year":"1998","journal-title":"Antisense Nucleic Acid Drug Dev"},{"issue":"5","key":"10.1016\/bs.pmbts.2021.01.027_bb0125","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.coph.2005.07.001","article-title":"Pharmacokinetics and biodistribution of phosphorodiamidate morpholino antisense oligomers","volume":"5","author":"Amantana","year":"2005","journal-title":"Curr Opin Pharmacol"},{"issue":"3","key":"10.1016\/bs.pmbts.2021.01.027_bb0130","doi-asserted-by":"crossref","first-page":"a028191","DOI":"10.1101\/cshperspect.a028191","article-title":"Ciliopathies","volume":"9","author":"Braun","year":"2017","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/bs.pmbts.2021.01.027_bb0135","series-title":"GeneReviews\u00ae","article-title":"Bardet-Biedl syndrome overview","author":"Forsyth","year":"1993"},{"key":"10.1016\/bs.pmbts.2021.01.027_bb0140","series-title":"GeneReviews\u00ae","article-title":"Alstr\u00f6m Syndrome","author":"Paisey","year":"1993"},{"issue":"02","key":"10.1016\/bs.pmbts.2021.01.027_bb0145","doi-asserted-by":"crossref","first-page":"049","DOI":"10.3233\/PGE-14089","article-title":"Clinical genetics and pathobiology of ciliary chondrodysplasias","volume":"03","author":"Schmidts","year":"2015","journal-title":"J Pediatr Genet"},{"key":"10.1016\/bs.pmbts.2021.01.027_bb0150","series-title":"GeneReviews\u00ae","article-title":"Oral-facial-digital syndrome type I","author":"Toriello","year":"1993"},{"issue":"1","key":"10.1016\/bs.pmbts.2021.01.027_bb0155","doi-asserted-by":"crossref","DOI":"10.1186\/s13630-016-0034-4","article-title":"Update on oral-facial-digital syndromes (OFDS)","volume":"5","author":"Franco","year":"2016","journal-title":"Cilia"},{"key":"10.1016\/bs.pmbts.2021.01.027_bb0160","series-title":"GeneReviews\u00ae","article-title":"Joubert syndrome","author":"Parisi","year":"1993"},{"key":"10.1016\/bs.pmbts.2021.01.027_bb0165","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3389\/fped.2017.00244","article-title":"Meckel-Gruber syndrome: an update on diagnosis, clinical management, and research advances","volume":"5","author":"Hartill","year":"2017","journal-title":"Front Pediatr"},{"key":"10.1016\/bs.pmbts.2021.01.027_bb0170","series-title":"GeneReviews\u00ae","article-title":"Leber congenital amaurosis\/early-onset severe retinal dystrophy overview","author":"Kumaran","year":"1993"},{"key":"10.1016\/bs.pmbts.2021.01.027_bb0175","series-title":"GeneReviews\u00ae","article-title":"Nonsyndromic retinitis pigmentosa overview","author":"Fahim","year":"1993"},{"key":"10.1016\/bs.pmbts.2021.01.027_bb0180","series-title":"GeneReviews(\u00ae)","article-title":"Polycystic kidney disease, autosomal dominant","author":"Harris","year":"1993"},{"key":"10.1016\/bs.pmbts.2021.01.027_bb0185","series-title":"GeneReviews\u00ae","article-title":"Polycystic kidney disease, autosomal recessive","author":"Sweeney","year":"1993"},{"key":"10.1016\/bs.pmbts.2021.01.027_bb0190","series-title":"GeneReviews\u00ae","article-title":"Nephronophthisis","author":"Stokman","year":"1993"},{"issue":"2","key":"10.1016\/bs.pmbts.2021.01.027_bb0195","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3233\/PGE-14086","article-title":"Nephronophthisis","volume":"3","author":"Srivastava","year":"2014","journal-title":"J Pediatr Genet"},{"key":"10.1016\/bs.pmbts.2021.01.027_bb0200","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.visres.2012.07.003","article-title":"Senior\u2013L\u00f8ken syndrome: a syndromic form of retinal dystrophy associated with nephronophthisis","volume":"75","author":"Ronquillo","year":"2012","journal-title":"Vision Res"},{"issue":"8","key":"10.1016\/bs.pmbts.2021.01.027_bb0205","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1136\/jmedgenet-2015-103087","article-title":"Joubert syndrome: a model for untangling recessive disorders with extreme genetic heterogeneity","volume":"52","author":"Bachmann-Gagescu","year":"2015","journal-title":"J Med Genet"},{"issue":"12","key":"10.1016\/bs.pmbts.2021.01.027_bb0210","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1002\/ajmg.a.34173","article-title":"Co-occurrence of distinct ciliopathy diseases in single families suggests genetic modifiers","volume":"155","author":"Zaki","year":"2011","journal-title":"Am J Med Genet A"},{"key":"10.1016\/bs.pmbts.2021.01.027_bb0215","doi-asserted-by":"crossref","first-page":"590","DOI":"10.12688\/f1000research.6959.1","article-title":"Murine Cep290 phenotypes are modified by genetic backgrounds and provide an impetus for investigating disease modifier alleles","volume":"4","author":"Ramsbottom","year":"2015","journal-title":"F1000Res"},{"issue":"2","key":"10.1016\/bs.pmbts.2021.01.027_bb0220","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1073\/pnas.1912602117","article-title":"Mouse genetics reveals Barttin as a genetic modifier of Joubert syndrome","volume":"117","author":"Ramsbottom","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/bs.pmbts.2021.01.027_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079369","article-title":"Unexpected CEP290 mRNA splicing in a humanized knock-in mouse model for leber congenital amaurosis","volume":"8","author":"Garanto","year":"2013","journal-title":"PLoS One"},{"issue":"1\u20132","key":"10.1016\/bs.pmbts.2021.01.027_bb0230","first-page":"97","article-title":"Retinal disease in ciliopathies: Recent advances with a focus on stem cell-based therapies","volume":"4","author":"Chen","year":"2019","journal-title":"Transl Sci Rare Dis"},{"issue":"1","key":"10.1016\/bs.pmbts.2021.01.027_bb0235","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms5047","article-title":"Generation of three-dimensional retinal tissue with functional photoreceptors from human iPSCs","volume":"5","author":"Zhong","year":"2014","journal-title":"Nat Commun"},{"issue":"7574","key":"10.1016\/bs.pmbts.2021.01.027_bb0240","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nature15695","article-title":"Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis","volume":"526","author":"Takasato","year":"2015","journal-title":"Nature"},{"issue":"11","key":"10.1016\/bs.pmbts.2021.01.027_bb0245","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/nbt.3392","article-title":"Nephron organoids derived from human pluripotent stem cells model kidney development and injury","volume":"33","author":"Morizane","year":"2015","journal-title":"Nat Biotechnol"},{"issue":"3","key":"10.1016\/bs.pmbts.2021.01.027_bb0250","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1086\/507318","article-title":"Mutations in the CEP290 (NPHP6) gene are a frequent cause of leber congenital amaurosis","volume":"79","author":"den Hollander","year":"2006","journal-title":"Am J Hum Genet"},{"issue":"6","key":"10.1016\/bs.pmbts.2021.01.027_bb0255","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.ophtha.2017.12.013","article-title":"Leber congenital amaurosis associated with mutations in CEP290, clinical phenotype, and natural history in preparation for trials of novel therapies","volume":"125","author":"Sheck","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/bs.pmbts.2021.01.027_bb0260","doi-asserted-by":"crossref","first-page":"109519","DOI":"10.1016\/j.cellsig.2019.109519","article-title":"Cilia in cystic kidney and other diseases","volume":"69","author":"Pazour","year":"2020","journal-title":"Cell Signal"},{"issue":"5891","key":"10.1016\/bs.pmbts.2021.01.027_bb0265","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1126\/science.1159689","article-title":"Small CRISPR RNAs guide antiviral defense in prokaryotes","volume":"321","author":"Brouns","year":"2008","journal-title":"Science"},{"issue":"6","key":"10.1016\/bs.pmbts.2021.01.027_bb0270","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.cell.2017.11.032","article-title":"The biology of CRISPR-Cas: backward and forward","volume":"172","author":"Hille","year":"2018","journal-title":"Cell"},{"issue":"5","key":"10.1016\/bs.pmbts.2021.01.027_bb0275","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1089\/crispr.2018.0033","article-title":"Classification and nomenclature of CRISPR-Cas systems: where from here?","volume":"1","author":"Makarova","year":"2018","journal-title":"CRISPR J"},{"issue":"7546","key":"10.1016\/bs.pmbts.2021.01.027_bb0280","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature14299","article-title":"In vivo genome editing using Staphylococcus aureus Cas9","volume":"520","author":"Ran","year":"2015","journal-title":"Nature"},{"issue":"7561","key":"10.1016\/bs.pmbts.2021.01.027_bb0285","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature14592","article-title":"Engineered CRISPR-Cas9 nucleases with altered PAM specificities","volume":"523","author":"Kleinstiver","year":"2015","journal-title":"Nature"},{"issue":"39","key":"10.1016\/bs.pmbts.2021.01.027_bb0290","doi-asserted-by":"crossref","first-page":"15644","DOI":"10.1073\/pnas.1313587110","article-title":"Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis","volume":"110","author":"Hou","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/bs.pmbts.2021.01.027_bb0295","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/nmeth.2681","article-title":"Orthogonal Cas9 proteins for RNA-guided gene regulation and editing","volume":"10","author":"Esvelt","year":"2013","journal-title":"Nat Methods"},{"issue":"5","key":"10.1016\/bs.pmbts.2021.01.027_bb0300","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.cell.2016.01.039","article-title":"Structure and engineering of Francisella novicida Cas9","volume":"164","author":"Hirano","year":"2016","journal-title":"Cell"},{"issue":"42","key":"10.1016\/bs.pmbts.2021.01.027_bb0305","doi-asserted-by":"crossref","first-page":"20959","DOI":"10.1073\/pnas.1818461116","article-title":"Francisella novicida Cas9 interrogates genomic DNA with very high specificity and can be used for mammalian genome editing","volume":"116","author":"Acharya","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/bs.pmbts.2021.01.027_bb0310","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aau0766","article-title":"Minimal PAM specificity of a highly similar SpCas9 ortholog","volume":"4","author":"Chatterjee","year":"2018","journal-title":"Sci Adv"},{"issue":"10","key":"10.1016\/bs.pmbts.2021.01.027_bb0315","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/s41587-020-0517-0","article-title":"An engineered ScCas9 with broad PAM range and high specificity and activity","volume":"38","author":"Chatterjee","year":"2020","journal-title":"Nat Biotechnol"},{"issue":"7490","key":"10.1016\/bs.pmbts.2021.01.027_bb0320","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nature13011","article-title":"DNA interrogation by the CRISPR RNA-guided endonuclease Cas9","volume":"507","author":"Sternberg","year":"2014","journal-title":"Nature"},{"issue":"5","key":"10.1016\/bs.pmbts.2021.01.027_bb0325","doi-asserted-by":"crossref","first-page":"726","DOI":"10.4161\/rna.24321","article-title":"The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems","volume":"10","author":"Chylinski","year":"2013","journal-title":"RNA Biol"},{"issue":"1","key":"10.1016\/bs.pmbts.2021.01.027_bb0330","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.1038\/s41467-020-19344-1","article-title":"A catalogue of biochemically diverse CRISPR-Cas9 orthologs","volume":"11","author":"Gasiunas","year":"2020","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/bs.pmbts.2021.01.027_bb0335","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.molcel.2016.02.020","article-title":"Structural plasticity of PAM recognition by engineered variants of the RNA-guided endonuclease Cas9","volume":"61","author":"Anders","year":"2016","journal-title":"Mol Cell"},{"issue":"9","key":"10.1016\/bs.pmbts.2021.01.027_bb0340","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1016\/j.celrep.2020.02.010","article-title":"High-throughput screens of PAM-flexible Cas9 variants for gene knockout and transcriptional modulation","volume":"30","author":"Legut","year":"2020","journal-title":"Cell Rep"},{"issue":"6488","key":"10.1016\/bs.pmbts.2021.01.027_bb0345","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1126\/science.aba8853","article-title":"Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants","volume":"368","author":"Walton","year":"2020","journal-title":"Science"},{"issue":"27","key":"10.1016\/bs.pmbts.2021.01.027_bb0350","doi-asserted-by":"crossref","first-page":"9798","DOI":"10.1073\/pnas.1402597111","article-title":"Direct observation of R-loop formation by single RNA-guided Cas9 and cascade effector complexes","volume":"111","author":"Szczelkun","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7519","key":"10.1016\/bs.pmbts.2021.01.027_bb0355","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nature13579","article-title":"Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease","volume":"513","author":"Anders","year":"2014","journal-title":"Nature"},{"issue":"8","key":"10.1016\/bs.pmbts.2021.01.027_bb0360","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nrm.2017.48","article-title":"Non-homologous DNA end joining and alternative pathways to double-strand break repair","volume":"18","author":"Chang","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"10.1016\/bs.pmbts.2021.01.027_bb0365","doi-asserted-by":"crossref","first-page":"a016535","DOI":"10.1101\/cshperspect.a016535","article-title":"Cell biology of mitotic recombination","volume":"7","author":"Lisby","year":"2015","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"10.1016\/bs.pmbts.2021.01.027_bb0370","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jmb.2018.06.037","article-title":"A CRISPR\u2013dCas toolbox for genetic engineering and synthetic biology","volume":"431","author":"Xu","year":"2019","journal-title":"J Mol Biol"},{"issue":"1","key":"10.1016\/bs.pmbts.2021.01.027_bb0375","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.cell.2016.09.006","article-title":"Inheritable silencing of endogenous genes by hit-and-run targeted epigenetic editing","volume":"167","author":"Amabile","year":"2016","journal-title":"Cell"},{"issue":"12","key":"10.1016\/bs.pmbts.2021.01.027_bb0380","doi-asserted-by":"crossref","first-page":"5615","DOI":"10.1093\/nar\/gkw159","article-title":"Repurposing the CRISPR-Cas9 system for targeted DNA methylation","volume":"44","author":"Vojta","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"10.1016\/bs.pmbts.2021.01.027_bb0385","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1242\/bio.019067","article-title":"Reprogrammable CRISPR\/Cas9-based system for inducing site-specific DNA methylation","volume":"5","author":"McDonald","year":"2016","journal-title":"Biol Open"},{"issue":"29","key":"10.1016\/bs.pmbts.2021.01.027_bb0390","doi-asserted-by":"crossref","first-page":"46545","DOI":"10.18632\/oncotarget.10234","article-title":"CRISPR-dCas9 mediated TET1 targeting for selective DNA demethylation at BRCA1 promoter","volume":"7","author":"Choudhury","year":"2016","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/bs.pmbts.2021.01.027_bb0395","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/nbt.3658","article-title":"Targeted DNA demethylation in vivo using dCas9\u2013peptide repeat and scFv\u2013TET1 catalytic domain fusions","volume":"34","author":"Morita","year":"2016","journal-title":"Nat Biotechnol"},{"issue":"1","key":"10.1016\/bs.pmbts.2021.01.027_bb0400","doi-asserted-by":"crossref","DOI":"10.1038\/celldisc.2016.9","article-title":"A CRISPR-based approach for targeted DNA demethylation","volume":"2","author":"Xu","year":"2016","journal-title":"Cell Discov"},{"issue":"5","key":"10.1016\/bs.pmbts.2021.01.027_bb0405","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/nbt.3199","article-title":"Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers","volume":"33","author":"Hilton","year":"2015","journal-title":"Nat Biotechnol"},{"issue":"5","key":"10.1016\/bs.pmbts.2021.01.027_bb0410","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nmeth.3325","article-title":"Functional annotation of native enhancers with a Cas9\u2013histone demethylase fusion","volume":"12","author":"Kearns","year":"2015","journal-title":"Nat Methods"},{"issue":"1","key":"10.1016\/bs.pmbts.2021.01.027_bb0415","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12284","article-title":"Writing of H3K4Me3 overcomes epigenetic silencing in a sustained but context-dependent manner","volume":"7","author":"Cano-Rodriguez","year":"2016","journal-title":"Nat Commun"},{"issue":"18","key":"10.1016\/bs.pmbts.2021.01.027_bb0420","doi-asserted-by":"crossref","first-page":"8868","DOI":"10.1093\/nar\/gkv874","article-title":"Cooperation between SMYD3 and PC4 drives a distinct transcriptional program in cancer cells","volume":"43","author":"Kim","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/bs.pmbts.2021.01.027_bb0425","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15315","article-title":"Locus-specific histone deacetylation using a synthetic CRISPR-Cas9-based HDAC","volume":"8","author":"Kwon","year":"2017","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/bs.pmbts.2021.01.027_bb0430","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.cell.2018.01.012","article-title":"Rescue of fragile X syndrome neurons by DNA methylation editing of the FMR1 gene","volume":"172","author":"Liu","year":"2018","journal-title":"Cell"},{"issue":"7603","key":"10.1016\/bs.pmbts.2021.01.027_bb0435","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature17946","article-title":"Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage","volume":"533","author":"Komor","year":"2016","journal-title":"Nature"},{"issue":"7681","key":"10.1016\/bs.pmbts.2021.01.027_bb0440","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nature24644","article-title":"Programmable base editing of A\u2022T to G\u2022C in genomic DNA without DNA cleavage","volume":"551","author":"Gaudelli","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/bs.pmbts.2021.01.027_bb0445","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-04580-3","article-title":"In vivo base editing of post-mitotic sensory cells","volume":"9","author":"Yeh","year":"2018","journal-title":"Nat Commun"},{"issue":"7699","key":"10.1016\/bs.pmbts.2021.01.027_bb0450","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature26155","article-title":"Evolved Cas9 variants with broad PAM compatibility and high DNA specificity","volume":"556","author":"Hu","year":"2018","journal-title":"Nature"},{"issue":"12","key":"10.1016\/bs.pmbts.2021.01.027_bb0455","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41576-018-0059-1","article-title":"Base editing: precision chemistry on the genome and transcriptome of living cells","volume":"19","author":"Rees","year":"2018","journal-title":"Nat Rev Genet"},{"issue":"1","key":"10.1016\/bs.pmbts.2021.01.027_bb0460","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15790","article-title":"Improving the DNA specificity and applicability of base editing through protein engineering and protein delivery","volume":"8","author":"Rees","year":"2017","journal-title":"Nat Commun"},{"issue":"7785","key":"10.1016\/bs.pmbts.2021.01.027_bb0465","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"issue":"20","key":"10.1016\/bs.pmbts.2021.01.027_bb0470","doi-asserted-by":"crossref","first-page":"9584","DOI":"10.1093\/nar\/gkt714","article-title":"CRISPR\/Cas9 systems targeting \u03b2-globin and CCR5 genes have substantial off-target activity","volume":"41","author":"Cradick","year":"2013","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"10.1016\/bs.pmbts.2021.01.027_bb0475","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nbt.2623","article-title":"High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells","volume":"31","author":"Fu","year":"2013","journal-title":"Nat Biotechnol"},{"key":"10.1016\/bs.pmbts.2021.01.027_bb0480","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.csbj.2019.11.006","article-title":"Computational approaches for effective CRISPR guide RNA design and evaluation","volume":"18","author":"Liu","year":"2020","journal-title":"Comput Struct Biotechnol J"},{"issue":"6268","key":"10.1016\/bs.pmbts.2021.01.027_bb0485","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.aad5227","article-title":"Rationally engineered Cas9 nucleases with improved specificity","volume":"351","author":"Slaymaker","year":"2016","journal-title":"Science"},{"issue":"7587","key":"10.1016\/bs.pmbts.2021.01.027_bb0490","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nature16526","article-title":"High-fidelity CRISPR\u2013Cas9 nucleases with no detectable genome-wide off-target effects","volume":"529","author":"Kleinstiver","year":"2016","journal-title":"Nature"},{"issue":"7676","key":"10.1016\/bs.pmbts.2021.01.027_bb0495","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nature24268","article-title":"Enhanced proofreading governs CRISPR\u2013Cas9 targeting accuracy","volume":"550","author":"Chen","year":"2017","journal-title":"Nature"},{"issue":"3","key":"10.1016\/bs.pmbts.2021.01.027_bb0500","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nbt.4066","article-title":"A highly specific SpCas9 variant is identified by in vivo screening in yeast","volume":"36","author":"Casini","year":"2018","journal-title":"Nat Biotechnol"},{"issue":"1","key":"10.1016\/bs.pmbts.2021.01.027_bb0505","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-05477-x","article-title":"Directed evolution of CRISPR-Cas9 to increase its specificity","volume":"9","author":"Lee","year":"2018","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/bs.pmbts.2021.01.027_bb0510","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/s41591-018-0137-0","article-title":"A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells","volume":"24","author":"Vakulskas","year":"2018","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/bs.pmbts.2021.01.027_bb0515","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.molcel.2020.02.023","article-title":"Highly parallel profiling of Cas9 variant specificity","volume":"78","author":"Schmid-Burgk","year":"2020","journal-title":"Mol Cell"},{"key":"10.1016\/bs.pmbts.2021.01.027_bb0520","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.copbio.2017.03.025","article-title":"Switchable Cas9","volume":"48","author":"Richter","year":"2017","journal-title":"Curr Opin Biotechnol"},{"issue":"1","key":"10.1016\/bs.pmbts.2021.01.027_bb0525","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15334","article-title":"Hit and go CAS9 delivered through a lentiviral based self-limiting circuit","volume":"8","author":"Petris","year":"2017","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/bs.pmbts.2021.01.027_bb0530","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/j.cell.2016.11.017","article-title":"Naturally occurring off-switches for CRISPR-Cas9","volume":"167","author":"Pawluk","year":"2016","journal-title":"Cell"},{"issue":"6411","key":"10.1016\/bs.pmbts.2021.01.027_bb0535","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1126\/science.aau5138","article-title":"Systematic discovery of natural CRISPR-Cas12a inhibitors","volume":"362","author":"Watters","year":"2018","journal-title":"Science"},{"issue":"3","key":"10.1016\/bs.pmbts.2021.01.027_bb0540","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.molcel.2018.11.016","article-title":"Temperature-responsive competitive inhibition of CRISPR-Cas9","volume":"73","author":"Jiang","year":"2019","journal-title":"Mol Cell"},{"issue":"2","key":"10.1016\/bs.pmbts.2021.01.027_bb0545","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.chom.2019.01.003","article-title":"Discovery and characterization of Cas9 inhibitors disseminated across seven bacterial phyla","volume":"25","author":"Uribe","year":"2019","journal-title":"Cell Host Microbe"},{"issue":"10","key":"10.1016\/bs.pmbts.2021.01.027_bb0550","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nmeth.3993","article-title":"A multifunctional AAV\u2013CRISPR\u2013Cas9 and its host response","volume":"13","author":"Chew","year":"2016","journal-title":"Nat Methods"},{"issue":"3","key":"10.1016\/bs.pmbts.2021.01.027_bb0555","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1101\/gr.231936.117","article-title":"CRISPR RNAs trigger innate immune responses in human cells","volume":"28","author":"Kim","year":"2018","journal-title":"Genome Res"},{"issue":"2","key":"10.1016\/bs.pmbts.2021.01.027_bb0560","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/s41591-018-0204-6","article-title":"High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population","volume":"25","author":"Wagner","year":"2019","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/bs.pmbts.2021.01.027_bb0565","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41591-018-0326-x","article-title":"Identification of preexisting adaptive immunity to Cas9 proteins in humans","volume":"25","author":"Charlesworth","year":"2019","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/bs.pmbts.2021.01.027_bb0570","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/s41591-018-0049-z","article-title":"CRISPR\u2013Cas9 genome editing induces a p53-mediated DNA damage response","volume":"24","author":"Haapaniemi","year":"2018","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/bs.pmbts.2021.01.027_bb0575","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/s41591-018-0050-6","article-title":"p53 inhibits CRISPR\u2013Cas9 engineering in human pluripotent stem cells","volume":"24","author":"Ihry","year":"2018","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/bs.pmbts.2021.01.027_bb0580","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41588-020-0623-4","article-title":"Cas9 activates the p53 pathway and selects for p53-inactivating mutations","volume":"52","author":"Enache","year":"2020","journal-title":"Nat Genet"},{"issue":"7798","key":"10.1016\/bs.pmbts.2021.01.027_bb0585","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/d41586-020-00655-8","article-title":"CRISPR treatment inserted directly into the body for first time","volume":"579","author":"Ledford","year":"2020","journal-title":"Nature"},{"key":"10.1016\/bs.pmbts.2021.01.027_bb0590","doi-asserted-by":"crossref","first-page":"101533","DOI":"10.1016\/j.jddst.2020.101533","article-title":"Nanoparticles-mediated CRISPR\/Cas9 delivery: recent advances in cancer treatment","volume":"56","author":"Aghamiri","year":"2020","journal-title":"J Drug Deliv Sci Technol"},{"issue":"4","key":"10.1016\/bs.pmbts.2021.01.027_bb0595","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/s11095-010-0338-9","article-title":"Hydrodynamic gene delivery and its applications in pharmaceutical research","volume":"28","author":"Bonamassa","year":"2011","journal-title":"Pharm Res"},{"issue":"1","key":"10.1016\/bs.pmbts.2021.01.027_bb0600","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1080\/10717544.2018.1474964","article-title":"Delivering CRISPR: a review of the challenges and approaches","volume":"25","author":"Lino","year":"2018","journal-title":"Drug Deliv"},{"issue":"6","key":"10.1016\/bs.pmbts.2021.01.027_bb0605","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nbt.2884","article-title":"Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype","volume":"32","author":"Yin","year":"2014","journal-title":"Nat Biotechnol"},{"issue":"2","key":"10.1016\/bs.pmbts.2021.01.027_bb0610","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/sj.gt.3302865","article-title":"Structural impact of hydrodynamic injection on mouse liver","volume":"14","author":"Suda","year":"2007","journal-title":"Gene Ther"},{"issue":"S1","key":"10.1016\/bs.pmbts.2021.01.027_bb0615","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/sj.gt.3302364","article-title":"Immune responses to gene therapy vectors: influence on vector function and effector mechanisms","volume":"11","author":"Bessis","year":"2004","journal-title":"Gene Ther"},{"issue":"3","key":"10.1016\/bs.pmbts.2021.01.027_bb0620","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1089\/hum.2006.17.253","article-title":"Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors","volume":"17","author":"Baum","year":"2006","journal-title":"Hum Gene Ther"},{"issue":"4","key":"10.1016\/bs.pmbts.2021.01.027_bb0625","first-page":"442","article-title":"Adeno-associated virus vector integration","volume":"11","author":"Deyle","year":"2009","journal-title":"Curr Opin Mol Ther"},{"issue":"R1","key":"10.1016\/bs.pmbts.2021.01.027_bb0630","doi-asserted-by":"crossref","first-page":"R42","DOI":"10.1093\/hmg\/ddv451","article-title":"Progress and challenges in viral vector manufacturing","volume":"25","author":"van der Loo","year":"2016","journal-title":"Hum Mol Genet"},{"issue":"1\u20132","key":"10.1016\/bs.pmbts.2021.01.027_bb0635","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ymgme.2003.08.016","article-title":"Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer","volume":"80","author":"Raper","year":"2003","journal-title":"Mol Genet Metab"},{"issue":"9","key":"10.1016\/bs.pmbts.2021.01.027_bb0640","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1172\/JCI35700","article-title":"Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1","volume":"118","author":"Hacein-Bey-Abina","year":"2008","journal-title":"J Clin Invest"},{"issue":"227","key":"10.1016\/bs.pmbts.2021.01.027_bb0645","doi-asserted-by":"crossref","first-page":"227ra33","DOI":"10.1126\/scitranslmed.3007280","article-title":"Gene therapy for Wiskott-Aldrich syndrome\u2014long-term efficacy and genotoxicity","volume":"6","author":"Braun","year":"2014","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/bs.pmbts.2021.01.027_bb0650","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nbt.3055","article-title":"In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9","volume":"33","author":"Swiech","year":"2015","journal-title":"Nat Biotechnol"},{"issue":"7","key":"10.1016\/bs.pmbts.2021.01.027_bb0655","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1167\/iovs.16-19316","article-title":"AAV-mediated CRISPR\/Cas gene editing of retinal cells in vivo","volume":"57","author":"Hung","year":"2016","journal-title":"Investig Opthalmol Vis Sci"},{"issue":"13","key":"10.1016\/bs.pmbts.2021.01.027_bb0660","doi-asserted-by":"crossref","first-page":"6450","DOI":"10.1093\/nar\/gkv601","article-title":"Development of an intein-mediated split\u2013Cas9 system for gene therapy","volume":"43","author":"Truong","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/bs.pmbts.2021.01.027_bb0665","doi-asserted-by":"crossref","DOI":"10.1038\/srep10777","article-title":"Trans-spliced Cas9 allows cleavage of HBB and CCR5 genes in human cells using compact expression cassettes","volume":"5","author":"Fine","year":"2015","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/bs.pmbts.2021.01.027_bb0670","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.cell.2014.02.001","article-title":"Crystal structure of Cas9 in complex with guide RNA and target DNA","volume":"156","author":"Nishimasu","year":"2014","journal-title":"Cell"},{"issue":"1","key":"10.1016\/bs.pmbts.2021.01.027_bb0675","doi-asserted-by":"crossref","first-page":"14500","DOI":"10.1038\/ncomms14500","article-title":"In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni","volume":"8","author":"Kim","year":"2017","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/bs.pmbts.2021.01.027_bb0680","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.cell.2015.09.038","article-title":"Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system","volume":"163","author":"Zetsche","year":"2015","journal-title":"Cell"},{"issue":"24","key":"10.1016\/bs.pmbts.2021.01.027_bb0685","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1002\/1873-3468.13691","article-title":"State-of-the-art human adenovirus vectorology for therapeutic approaches","volume":"593","author":"Gao","year":"2019","journal-title":"FEBS Lett"},{"issue":"7","key":"10.1016\/bs.pmbts.2021.01.027_bb0690","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/s41375-018-0106-0","article-title":"Clinical use of lentiviral vectors","volume":"32","author":"Milone","year":"2018","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/bs.pmbts.2021.01.027_bb0695","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-associated virus vector as a platform for gene therapy delivery","volume":"18","author":"Wang","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/bs.pmbts.2021.01.027_bb0700","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.omtn.2018.05.010","article-title":"VSV-G-enveloped vesicles for traceless delivery of CRISPR-Cas9","volume":"12","author":"Montagna","year":"2018","journal-title":"Mol Ther\u2013Nucleic Acids"},{"issue":"21","key":"10.1016\/bs.pmbts.2021.01.027_bb0705","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1056\/NEJMoa0802268","article-title":"Effect of gene therapy on visual function in Leber's congenital amaurosis","volume":"358","author":"Bainbridge","year":"2008","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/bs.pmbts.2021.01.027_bb0710","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1089\/hum.2008.107","article-title":"Treatment of Leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial","volume":"19","author":"Hauswirth","year":"2008","journal-title":"Hum Gene Ther"},{"issue":"21","key":"10.1016\/bs.pmbts.2021.01.027_bb0715","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1056\/NEJMoa0802315","article-title":"Safety and efficacy of gene transfer for Leber's congenital amaurosis","volume":"358","author":"Maguire","year":"2008","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/bs.pmbts.2021.01.027_bb0720","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1038\/mt.2009.181","article-title":"Inner limiting membrane barriers to AAV-mediated retinal transduction from the vitreous","volume":"17","author":"Dalkara","year":"2009","journal-title":"Mol Ther"},{"issue":"5","key":"10.1016\/bs.pmbts.2021.01.027_bb0725","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1167\/iovs.10-6250","article-title":"Intravitreal injection of AAV2 transduces macaque inner retina","volume":"52","author":"Yin","year":"2011","journal-title":"Investig Opthalmol Vis Sci"},{"key":"10.1016\/bs.pmbts.2021.01.027_bb0730","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.6317","article-title":"Evaluation of AAV-DJ vector for retinal gene therapy","volume":"7","author":"Katada","year":"2019","journal-title":"PeerJ"},{"issue":"9","key":"10.1016\/bs.pmbts.2021.01.027_bb0735","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1167\/iovs.07-0257","article-title":"AAV-mediated expression targeting of rod and cone photoreceptors with a human rhodopsin kinase promoter","volume":"48","author":"Khani","year":"2007","journal-title":"Investig Opthalmol Vis Sci"},{"issue":"1","key":"10.1016\/bs.pmbts.2021.01.027_bb0740","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/gt.2009.104","article-title":"Gene therapy with a promoter targeting both rods and cones rescues retinal degeneration caused by AIPL1 mutations","volume":"17","author":"Sun","year":"2010","journal-title":"Gene Ther"},{"issue":"9","key":"10.1016\/bs.pmbts.2021.01.027_bb0745","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1152\/physiolgenomics.00052.2019","article-title":"Gene therapy research for kidney diseases","volume":"51","author":"Davis","year":"2019","journal-title":"Physiol Genomics"},{"issue":"12","key":"10.1016\/bs.pmbts.2021.01.027_bb0750","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1089\/hum.2019.127","article-title":"Comparison of gene delivery to the kidney by adenovirus, adeno-associated virus, and lentiviral vectors after intravenous and direct kidney injections","volume":"30","author":"Rubin","year":"2019","journal-title":"Hum Gene Ther"},{"issue":"1","key":"10.1016\/bs.pmbts.2021.01.027_bb0755","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000333071","article-title":"Adeno-associated virus-mediated gene transfer to renal tubule cells via a retrograde ureteral approach","volume":"1","author":"Chung","year":"2011","journal-title":"Nephron Extra"},{"issue":"3","key":"10.1016\/bs.pmbts.2021.01.027_bb0760","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1046\/j.1523-1755.2003.00827.x","article-title":"An in vivo method for adenovirus-mediated transduction of thick ascending limbs","volume":"63","author":"Ortiz","year":"2003","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/bs.pmbts.2021.01.027_bb0765","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1161\/01.HYP.0000085561.00001.81","article-title":"Gene transfer of eNOS to the thick ascending limb of eNOS-KO mice restores the effects of l -arginine on NaCl absorption","volume":"42","author":"Ortiz","year":"2003","journal-title":"Hypertension"},{"issue":"29","key":"10.1016\/bs.pmbts.2021.01.027_bb0770","doi-asserted-by":"crossref","first-page":"17594","DOI":"10.1074\/jbc.270.29.17594","article-title":"Isolation and cDNA cloning of Ksp-cadherin, a novel kidney-specific member of the cadherin multigene family","volume":"270","author":"Thomson","year":"1995","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/bs.pmbts.2021.01.027_bb0775","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bbrc.2018.01.169","article-title":"Nephron segment-specific gene expression using AAV vectors","volume":"497","author":"Asico","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"10.1016\/bs.pmbts.2021.01.027_bb0780","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/01.ASN.0000057858.45649.F7","article-title":"Gene delivery in renal tubular epithelial cells using recombinant adeno-associated viral vectors","volume":"14","author":"Chen","year":"2003","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/bs.pmbts.2021.01.027_bb0785","doi-asserted-by":"crossref","DOI":"10.1002\/wrna.1594","article-title":"The powerful world of antisense oligonucleotides: From bench to bedside","volume":"11","author":"Quemener","year":"2020","journal-title":"WIREs RNA"},{"issue":"4","key":"10.1016\/bs.pmbts.2021.01.027_bb0790","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.cmet.2018.03.004","article-title":"RNA-targeted therapeutics","volume":"27","author":"Crooke","year":"2018","journal-title":"Cell Metab"},{"issue":"10","key":"10.1016\/bs.pmbts.2021.01.027_bb0795","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41573-020-0075-7","article-title":"Advances in oligonucleotide drug delivery","volume":"19","author":"Roberts","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/bs.pmbts.2021.01.027_bb0800","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.omtn.2018.07.010","article-title":"Splice-modulating oligonucleotide QR-110 restores CEP290 mRNA and function in human c.2991+1655A>G LCA10 models","volume":"12","author":"Dulla","year":"2018","journal-title":"Mol Ther\u2013Nucleic Acids"},{"issue":"14","key":"10.1016\/bs.pmbts.2021.01.027_bb0805","doi-asserted-by":"crossref","first-page":"6518","DOI":"10.1093\/nar\/gkw236","article-title":"The delivery of therapeutic oligonucleotides","volume":"44","author":"Juliano","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/bs.pmbts.2021.01.027_bb0810","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-11918-y","article-title":"Discovery and preclinical evaluation of anti-miR-17 oligonucleotide RGLS4326 for the treatment of polycystic kidney disease","volume":"10","author":"Lee","year":"2019","journal-title":"Nat Commun"},{"issue":"49","key":"10.1016\/bs.pmbts.2021.01.027_bb0815","doi-asserted-by":"crossref","first-page":"12489","DOI":"10.1073\/pnas.1809432115","article-title":"Targeted exon skipping of a CEP290 mutation rescues Joubert syndrome phenotypes in vitro and in a murine model","volume":"115","author":"Ramsbottom","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/bs.pmbts.2021.01.027_bb0820","series-title":"Gapmers","first-page":"57","article-title":"Development of antisense oligonucleotide gapmers for the treatment of Huntington's disease","volume":"vol 2176","author":"Aslesh","year":"2020"},{"issue":"16","key":"10.1016\/bs.pmbts.2021.01.027_bb0825","doi-asserted-by":"crossref","first-page":"9528","DOI":"10.1093\/nar\/gkx632","article-title":"Antisense oligonucleotides targeting translation inhibitory elements in 5\u2019 UTRs can selectively increase protein levels","volume":"45","author":"Liang","year":"2017","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"10.1016\/bs.pmbts.2021.01.027_bb0830","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.ymthe.2019.06.016","article-title":"Steric Inhibition of 5\u2032 UTR regulatory elements results in upregulation of human CFTR","volume":"27","author":"Sasaki","year":"2019","journal-title":"Mol Ther"},{"issue":"10","key":"10.1016\/bs.pmbts.2021.01.027_bb0835","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1089\/hum.2014.086","article-title":"Translational and regulatory challenges for exon skipping therapies","volume":"25","author":"Aartsma-Rus","year":"2014","journal-title":"Hum Gene Ther"},{"issue":"1","key":"10.1016\/bs.pmbts.2021.01.027_bb0840","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1038\/s41467-020-17093-9","article-title":"Antisense oligonucleotide modulation of non-productive alternative splicing upregulates gene expression","volume":"11","author":"Lim","year":"2020","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/bs.pmbts.2021.01.027_bb0845","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1371\/journal.pbio.0050073","article-title":"Enhancement of SMN2 exon 7 inclusion by antisense oligonucleotides targeting the exon","volume":"5","author":"Hua","year":"2007","journal-title":"PLoS Biol"},{"issue":"6","key":"10.1016\/bs.pmbts.2021.01.027_bb0850","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1172\/JCI120429","article-title":"Gene therapy and genome surgery in the retina","volume":"128","author":"DiCarlo","year":"2018","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/bs.pmbts.2021.01.027_bb0855","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.stemcr.2018.02.003","article-title":"Gene correction reverses ciliopathy and photoreceptor loss in iPSC-derived retinal organoids from retinitis pigmentosa patients","volume":"10","author":"Deng","year":"2018","journal-title":"Stem Cell Rep"},{"issue":"1","key":"10.1016\/bs.pmbts.2021.01.027_bb0860","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-06448-y","article-title":"Disrupted alternative splicing for genes implicated in splicing and ciliogenesis causes PRPF31 retinitis pigmentosa","volume":"9","author":"Buskin","year":"2018","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/bs.pmbts.2021.01.027_bb0865","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/17469899.2016.1251316","article-title":"In vivo versus ex vivo CRISPR therapies for retinal dystrophy","volume":"11","author":"Bakondi","year":"2016","journal-title":"Expert Rev Ophthalmol"},{"issue":"4","key":"10.1016\/bs.pmbts.2021.01.027_bb0870","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/ng774","article-title":"Nrl is required for rod photoreceptor development","volume":"29","author":"Mears","year":"2001","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/bs.pmbts.2021.01.027_bb0875","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1167\/iovs.04-1427","article-title":"Cone-like morphological, molecular, and electrophysiological features of the photoreceptors of the Nrl knockout mouse","volume":"46","author":"Daniele","year":"2005","journal-title":"Investig Opthalmol Vis Sci"},{"issue":"5","key":"10.1016\/bs.pmbts.2021.01.027_bb0880","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1073\/pnas.1214387110","article-title":"Reprogramming of adult rod photoreceptors prevents retinal degeneration","volume":"110","author":"Montana","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/bs.pmbts.2021.01.027_bb0885","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14716","article-title":"Nrl knockdown by AAV-delivered CRISPR\/Cas9 prevents retinal degeneration in mice","volume":"8","author":"Yu","year":"2017","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/bs.pmbts.2021.01.027_bb0890","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/7678","article-title":"A mutation in NRL is associated with autosomal dominant retinitis pigmentosa","volume":"21","author":"Bessant","year":"1999","journal-title":"Nat Genet"},{"issue":"51","key":"10.1016\/bs.pmbts.2021.01.027_bb0895","doi-asserted-by":"crossref","first-page":"17819","DOI":"10.1073\/pnas.0408183101","article-title":"Recessive NRL mutations in patients with clumped pigmentary retinal degeneration and relative preservation of blue cone function","volume":"101","author":"Nishiguchi","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/bs.pmbts.2021.01.027_bb0900","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1517\/14728222.2012.680956","article-title":"Ciliary transition zone (TZ) proteins RPGR and CEP290: role in photoreceptor cilia and degenerative diseases","volume":"16","author":"Anand","year":"2012","journal-title":"Expert Opin Ther Targets"},{"issue":"2","key":"10.1016\/bs.pmbts.2021.01.027_bb0905","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ymthe.2016.12.006","article-title":"CRISPR\/Cas9-mediated genome editing as a therapeutic approach for leber congenital amaurosis 10","volume":"25","author":"Ruan","year":"2017","journal-title":"Mol Ther"},{"issue":"2","key":"10.1016\/bs.pmbts.2021.01.027_bb0910","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41591-018-0327-9","article-title":"Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10","volume":"25","author":"Maeder","year":"2019","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/bs.pmbts.2021.01.027_bb0915","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.stem.2019.06.009","article-title":"Generation of human PSC-derived kidney organoids with patterned nephron segments and a de novo vascular network","volume":"25","author":"Low","year":"2019","journal-title":"Cell Stem Cell"},{"issue":"5","key":"10.1016\/bs.pmbts.2021.01.027_bb0920","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.ajhg.2018.03.014","article-title":"Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype and reveal underlying pathogenetic mechanisms","volume":"102","author":"Forbes","year":"2018","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1016\/bs.pmbts.2021.01.027_bb0925","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/xen.12161","article-title":"Evaluation of human and non-human primate antibody binding to pig cells lacking GGTA1\/CMAH\/\u03b24GalNT2 genes","volume":"22","author":"Estrada","year":"2015","journal-title":"Xenotransplantation"},{"issue":"6357","key":"10.1016\/bs.pmbts.2021.01.027_bb0930","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1126\/science.aan4187","article-title":"Inactivation of porcine endogenous retrovirus in pigs using CRISPR-Cas9","volume":"357","author":"Niu","year":"2017","journal-title":"Science"},{"issue":"3","key":"10.1016\/bs.pmbts.2021.01.027_bb0935","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/890","article-title":"Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases","volume":"19","author":"Okano","year":"1998","journal-title":"Nat Genet"},{"issue":"11","key":"10.1016\/bs.pmbts.2021.01.027_bb0940","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.febslet.2009.04.012","article-title":"CpG islands\u2014\u2018A rough guide.\u2019","volume":"583","author":"Illingworth","year":"2009","journal-title":"FEBS Lett"},{"issue":"5","key":"10.1016\/bs.pmbts.2021.01.027_bb0945","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0092-8674(00)81532-9","article-title":"Methylation-induced repression\u2014belts, braces, and chromatin","volume":"99","author":"Bird","year":"1999","journal-title":"Cell"},{"issue":"4","key":"10.1016\/bs.pmbts.2021.01.027_bb0950","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/hmg\/ddq513","article-title":"Replication timing-related and gene body-specific methylation of active human genes","volume":"20","author":"Aran","year":"2011","journal-title":"Hum Mol Genet"},{"issue":"12","key":"10.1016\/bs.pmbts.2021.01.027_bb0955","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.bbagrm.2014.02.007","article-title":"Understanding the relationship between DNA methylation and histone lysine methylation","volume":"1839","author":"Rose","year":"2014","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"issue":"4","key":"10.1016\/bs.pmbts.2021.01.027_bb0960","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","article-title":"Chromatin modifications and their function","volume":"128","author":"Kouzarides","year":"2007","journal-title":"Cell"},{"issue":"1","key":"10.1016\/bs.pmbts.2021.01.027_bb0965","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrg2485","article-title":"The many roles of histone deacetylases in development and physiology: implications for disease and therapy","volume":"10","author":"Haberland","year":"2009","journal-title":"Nat Rev Genet"},{"issue":"5","key":"10.1016\/bs.pmbts.2021.01.027_bb0970","first-page":"246","article-title":"Role of epigenetics in biology and human diseases","author":"Moosavi","year":"2016","journal-title":"Iran Biomed J"},{"issue":"1","key":"10.1016\/bs.pmbts.2021.01.027_bb0975","doi-asserted-by":"crossref","DOI":"10.1186\/s13148-019-0776-0","article-title":"The timeline of epigenetic drug discovery: from reality to dreams","volume":"11","author":"Ganesan","year":"2019","journal-title":"Clin Epigenetics"},{"issue":"12","key":"10.1016\/bs.pmbts.2021.01.027_bb0980","doi-asserted-by":"crossref","first-page":"e1558","DOI":"10.1038\/cddis.2014.512","article-title":"DNA methylation and differential gene regulation in photoreceptor cell death","volume":"5","author":"Farinelli","year":"2014","journal-title":"Cell Death Dis"},{"issue":"3","key":"10.1016\/bs.pmbts.2021.01.027_bb0985","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-018-0349-8","article-title":"DZNep inhibits H3K27me3 deposition and delays retinal degeneration in the rd1 mice","volume":"9","author":"Zheng","year":"2018","journal-title":"Cell Death Dis"},{"issue":"2","key":"10.1016\/bs.pmbts.2021.01.027_bb0990","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1038\/cddis.2010.4","article-title":"Excessive HDAC activation is critical for neurodegeneration in the rd1 mouse","volume":"1","author":"Sancho-Pelluz","year":"2010","journal-title":"Cell Death Dis"},{"issue":"5911","key":"10.1016\/bs.pmbts.2021.01.027_bb0995","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1126\/science.1166226","article-title":"HDAC4 regulates neuronal survival in normal and diseased retinas","volume":"323","author":"Chen","year":"2009","journal-title":"Science"},{"issue":"1","key":"10.1016\/bs.pmbts.2021.01.027_bb1000","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms9005","article-title":"A short N-terminal domain of HDAC4 preserves photoreceptors and restores visual function in retinitis pigmentosa","volume":"6","author":"Guo","year":"2015","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/bs.pmbts.2021.01.027_bb1005","doi-asserted-by":"crossref","DOI":"10.1038\/srep15238","article-title":"Epigenetic silencing of the MUPCDH gene as a possible prognostic biomarker for cyst growth in ADPKD","volume":"5","author":"Woo","year":"2015","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/bs.pmbts.2021.01.027_bb1010","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00439-013-1378-0","article-title":"Genome-wide methylation profiling of ADPKD identified epigenetically regulated genes associated with renal cyst development","volume":"133","author":"Woo","year":"2014","journal-title":"Hum Genet"},{"issue":"6","key":"10.1016\/bs.pmbts.2021.01.027_bb1015","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1159\/000494739","article-title":"Genome-scale single nucleotide resolution analysis of DNA methylation in human autosomal dominant polycystic kidney disease","volume":"48","author":"Bowden","year":"2018","journal-title":"Am J Nephrol"},{"key":"10.1016\/bs.pmbts.2021.01.027_bb1020","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2020.00348","article-title":"Extensive inter-cyst DNA methylation variation in autosomal dominant polycystic kidney disease revealed by genome scale sequencing","volume":"11","author":"Bowden","year":"2020","journal-title":"Front Genet"},{"issue":"51","key":"10.1016\/bs.pmbts.2021.01.027_bb1025","doi-asserted-by":"crossref","first-page":"21819","DOI":"10.1073\/pnas.0911987106","article-title":"Chemical modifier screen identifies HDAC inhibitors as suppressors of PKD models","volume":"106","author":"Cao","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/bs.pmbts.2021.01.027_bb1030","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1242\/dev.049437","article-title":"Polycystin-dependent fluid flow sensing targets histone deacetylase 5 to prevent the development of renal cysts","volume":"137","author":"Xia","year":"2010","journal-title":"Development"},{"issue":"1","key":"10.1016\/bs.pmbts.2021.01.027_bb1035","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ki.2011.296","article-title":"Inhibition of histone deacetylases targets the transcription regulator Id2 to attenuate cystic epithelial cell proliferation","volume":"81","author":"Fan","year":"2012","journal-title":"Kidney Int"},{"issue":"7","key":"10.1016\/bs.pmbts.2021.01.027_bb1040","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1172\/JCI64401","article-title":"Sirtuin 1 inhibition delays cyst formation in autosomal-dominant polycystic kidney disease","volume":"123","author":"Zhou","year":"2013","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/bs.pmbts.2021.01.027_bb1045","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.kint.2016.01.026","article-title":"Inhibition of histone deacetylase 6 activity reduces cyst growth in polycystic kidney disease","volume":"90","author":"Cebotaru","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/bs.pmbts.2021.01.027_bb1050","article-title":"Opportunities and challenges for molecular understanding of ciliopathies\u2014the 100,000 genomes project","volume":"10","author":"Wheway","year":"2019","journal-title":"Front Genet"},{"issue":"14","key":"10.1016\/bs.pmbts.2021.01.027_bb1055","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1093\/hmg\/ddaa124","article-title":"Limited time window for retinal gene therapy in a preclinical model of ciliopathy","volume":"29","author":"Datta","year":"2020","journal-title":"Hum Mol Genet"},{"issue":"7544","key":"10.1016\/bs.pmbts.2021.01.027_bb1060","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/519410a","article-title":"Don\u2019t edit the human germ line","volume":"519","author":"Lanphier","year":"2015","journal-title":"Nature"},{"issue":"7794","key":"10.1016\/bs.pmbts.2021.01.027_bb1065","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41586-020-1978-5","article-title":"The promise and challenge of therapeutic genome editing","volume":"578","author":"Doudna","year":"2020","journal-title":"Nature"},{"issue":"3","key":"10.1016\/bs.pmbts.2021.01.027_bb1070","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/jlb\/lsx030","article-title":"Paving the road to personalized medicine: recommendations on regulatory, intellectual property and reimbursement challenges","volume":"4","author":"Knowles","year":"2017","journal-title":"J Law Biosci"}],"container-title":["Progress in Molecular Biology and Translational Science","Curing Genetic Diseases Through Genome Reprogramming"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117321000387?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117321000387?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T19:53:47Z","timestamp":1681761227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877117321000387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9780323853019"],"references-count":213,"URL":"https:\/\/doi.org\/10.1016\/bs.pmbts.2021.01.027","relation":{},"ISSN":["1877-1173"],"issn-type":[{"type":"print","value":"1877-1173"}],"subject":[],"published":{"date-parts":[[2021]]}}}